| Tretinoin | Approved Investigational Nutraceutical | PLEKHA6 | 22874 |
upregulated | Tretinoin results in increased expression of PLEKHA6 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PLEKHA7 | 144100 |
downregulated | Tretinoin results in decreased expression of PLEKHA7 mRNA | 11p15 | |
| Tretinoin | Approved Investigational Nutraceutical | PLEKHG4B | 153478 |
downregulated | Tretinoin results in decreased expression of PLEKHG4B mRNA | 5p15.33 | |
| Tretinoin | Approved Investigational Nutraceutical | PLEKHH1 | 57475 |
upregulated | Tretinoin results in increased expression of PLEKHH1 mRNA | 14q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PLEKHS1 | 79949 |
upregulated | Tretinoin results in increased expression of PLEKHS1 mRNA | 10q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PLIN2 | 123 |
upregulated | Tretinoin results in increased expression of PLIN2 mRNA | 9p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PLIN5 | 440503 |
downregulated | Tretinoin results in decreased expression of PLIN5 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PLK1 | 5347 |
downregulated | Tretinoin results in decreased expression of PLK1 mRNA | 16p12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLK2 | 10769 |
upregulated | Tretinoin results in increased expression of PLK2 mRNA | 5q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLK4 | 10733 |
downregulated | Tretinoin results in decreased expression of PLK4 mRNA | 4q28.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PLN | 5350 |
upregulated | Tretinoin results in increased expression of PLN mRNA | 6q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | PLOD2 | 5352 |
upregulated | Tretinoin results in increased expression of PLOD2 mRNA | 3q24 | |
| Tretinoin | Approved Investigational Nutraceutical | PLP1 | 5354 |
downregulated | Tretinoin results in decreased expression of PLP1 mRNA | Xq22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLP2 | 5355 |
downregulated | Tretinoin results in decreased expression of PLP2 mRNA | Xp11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | PLPP1 | 8611 |
upregulated | Tretinoin results in increased expression of PLPP1 mRNA | 5q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLPP2 | 8612 |
downregulated | Tretinoin results in decreased expression of PLPP2 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PLPP3 | 8613 |
downregulated | Tretinoin results in decreased expression of PLPP3 mRNA | 1p32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLPP4 | 196051 |
upregulated | Tretinoin results in increased expression of PLPP4 mRNA | 10q26.12 | |
| Tretinoin | Approved Investigational Nutraceutical | PLPPR4 | 9890 |
downregulated | Tretinoin results in decreased expression of PLPPR4 mRNA | 1p21.3-p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLSCR1 | 5359 |
upregulated | Tretinoin results in increased expression of PLSCR1 mRNA | 3q24 | |
| Tretinoin | Approved Investigational Nutraceutical | PLTP | 5360 |
downregulated | Tretinoin results in decreased expression of PLTP mRNA | 20q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | PLTP | 5360 |
upregulated | Tretinoin results in increased expression of PLTP mRNA | 20q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | PLXNA2 | 5362 |
upregulated | Tretinoin results in increased expression of PLXNA2 mRNA | 1q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PLXNC1 | 10154 |
downregulated | Tretinoin results in decreased expression of PLXNC1 mRNA | 12q22 | |
| Tretinoin | Approved Investigational Nutraceutical | PLXND1 | 23129 |
downregulated | Tretinoin results in decreased expression of PLXND1 mRNA | 3q22.1 | |